NCS Clinical Decision-Making 1 — Questions and Answers
Question 1: What is the primary goal of using clinical decision-making frameworks in neurologic practice?
- To ensure all patients receive the same treatment regardless of their condition
- To streamline documentation processes
- To make informed, evidence-based decisions tailored to individual patient needs (Correct answer)
- To reduce the number of diagnostic tests ordered
Correct answer: To make informed, evidence-based decisions tailored to individual patient needs
Clinical decision-making frameworks provide a structured approach for healthcare professionals to integrate the best available research evidence, clinical expertise, and patient values. Their primary goal is to guide the development of individualized, evidence-based treatment plans. This ensures that interventions are tailored to each patient's unique condition, preferences, and circumstances, leading to optimal and effective care.
Question 2: When assessing a patient with suspected multiple sclerosis (MS), which of the following findings would be most indicative of an acute exacerbation?
- Persistent, low-grade fever
- A sudden increase in spasticity (Correct answer)
- Stable visual acuity without changes
- Stable mood with no new cognitive symptoms
Correct answer: A sudden increase in spasticity
An acute exacerbation, or relapse, in multiple sclerosis (MS) is characterized by new neurological symptoms or a worsening of existing symptoms lasting at least 24 hours, in the absence of fever or infection. A sudden increase in spasticity indicates new inflammation and demyelination in the central nervous system, which is the hallmark of an MS relapse. Other options like stable visual acuity or mood would suggest stability, not an acute exacerbation.
Question 3: In the context of clinical decision-making for a patient with Parkinson’s disease, which of the following interventions would most likely be recommended to address motor fluctuations?
- Increasing the frequency of physical therapy sessions
- Introducing a dopamine agonist medication (Correct answer)
- Implementing a high-protein diet
- Reducing the dosage of levodopa
Correct answer: Introducing a dopamine agonist medication
Motor fluctuations in Parkinson's disease, such as 'wearing off' or dyskinesias, occur as the effectiveness of levodopa fluctuates throughout the day. Dopamine agonists mimic the effect of dopamine in the brain, providing a more continuous dopaminergic stimulation. This helps to smooth out motor fluctuations, extend 'on' times, and improve overall motor control, making them a key intervention for managing these symptoms.
Question 4: Which diagnostic tool is most useful for differentiating between a primary brain tumor and a metastatic brain lesion?
- Electroencephalogram (EEG)
- Computed Tomography (CT) scan
- Magnetic Resonance Imaging (MRI) with contrast (Correct answer)
- Positron Emission Tomography (PET) scan
Correct answer: Magnetic Resonance Imaging (MRI) with contrast
Magnetic Resonance Imaging (MRI) with contrast is the most useful diagnostic tool for differentiating between a primary brain tumor and a metastatic brain lesion. MRI provides superior soft tissue resolution compared to CT scans, allowing for detailed visualization of lesion characteristics, surrounding edema, and patterns of enhancement with contrast. These features, along with location and multiplicity, often help distinguish between the two types of tumors.
Question 5: What is the best approach for managing a patient with chronic migraine who has not responded to first-line pharmacological treatments?
- Discontinue all medications and recommend lifestyle changes only
- Consider a second-line medication such as a CGRP inhibitor (Correct answer)
- Increase the dosage of the initial medication to maximum levels
- Recommend immediate surgical intervention
Correct answer: Consider a second-line medication such as a CGRP inhibitor
For patients with chronic migraine who have not responded to first-line pharmacological treatments, it is appropriate to consider second-line options. CGRP (calcitonin gene-related peptide) inhibitors are a newer class of medications specifically designed to target the CGRP pathway, which plays a crucial role in migraine pathophysiology. They have demonstrated significant efficacy in reducing migraine frequency and severity in patients refractory to other treatments, offering a targeted and effective alternative.
NCS Clinical Decision-Making 1
What is the primary goal of using clinical decision-making frameworks in neurologic practice?